Document Detail


Plasma homocysteine concentration in children with chronic renal failure.
MedLine Citation:
PMID:  11605787     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hyperhomocysteinemia, a risk factor for vascular disease, is commonly found in adult patients with end-stage renal disease. Major determinants of elevated plasma homocysteine levels in these patients include deficiencies in folate and vitamin B12, methylenetetrahydrofolate reductase (MTHFR) genotype and renal function. Little information is available for children with chronic renal failure (CRF). The prevalence and the factors that affect plasma homocysteine concentration were determined in children. Twenty-nine children with various degrees of CRF (15 were dialyzed, 14 were not dialyzed) were compared with 57 age- and sex-matched healthy children. Homocysteine concentrations were higher in patients than controls (17.3 micromol/l vs 6.8 micromol/l, P<0.0001) and hyperhomocysteinemia (>95th percentile for controls: 14.0 micromol/l) was seen in 62.0% of patients and 5.2% of controls. Folate concentrations were lower in patients (9.9 nmol/l) than controls (13.5 nmol/l), P<0.01. Vitamin B12 was similar in patients (322 pmol/l) and controls (284 pmol/l). Dialyzed patients have a higher prevalence of hyperhomocysteinemia than nondialyzed patients (87% vs 35%). Dialyzed patients with MTHFR mutation have higher plasma homocysteine (28.5 micromol/l) than nondialyzed patients with the mutation (10.7 micromol/l), P<0.002. In our study, differences between controls and patients in plasma homocysteine concentrations are observed when age is greater then 92 months, folate less than 21.6 nmol/l and vitamin B12 less than 522 pmol/l. Our study shows that hyperhomocysteinemia is common in children with CRF and is associated with low folate and normal vitamin B12 status, compared to normal children. Among the patients, the dialyzed patients with the MTHFR mutation are particularly at risk for hyperhomocysteinemia. Further studies are needed to investigate therapeutic interventions and the potential link with vascular complications in these patients.
Authors:
A Merouani; M Lambert; E E Delvin; J Genest; P Robitaille; R Rozen
Related Documents :
8063947 - Hypercalcaemia in hodgkin's disease related to prostaglandin synthesis.
16047647 - Maxacalcitol therapy decreases circulating osteoprotegerin levels in dialysis patients ...
18848507 - Vitamin d deficiency in preoperative bariatric surgery patients.
18469307 - Reduction of the genomic damage level in haemodialysis patients by folic acid and vitam...
20383097 - Frequency and characteristics of tooth agenesis among an orthodontic patient population.
16943847 - Resting energy expenditure and its determinants in hemodialysis patients.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pediatric nephrology (Berlin, Germany)     Volume:  16     ISSN:  0931-041X     ISO Abbreviation:  Pediatr. Nephrol.     Publication Date:  2001 Oct 
Date Detail:
Created Date:  2001-10-18     Completed Date:  2002-03-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8708728     Medline TA:  Pediatr Nephrol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  805-11     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Ste-Justine Hospital, University of Montréal, Canada. merouana@ere.umontreal.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Aging / metabolism
Child
Child, Preschool
Diet
Female
Folic Acid Deficiency / blood
Genotype
Homocysteine / blood*
Humans
Infant
Kidney Failure, Chronic / blood*
Kidney Function Tests
Male
Methylenetetrahydrofolate Reductase (NADPH2)
Oxidoreductases Acting on CH-NH Group Donors / genetics,  metabolism
Reference Values
Renal Dialysis
Vitamin B 12 / blood
Chemical
Reg. No./Substance:
454-28-4/Homocysteine; 68-19-9/Vitamin B 12; EC 1.5.-/Oxidoreductases Acting on CH-NH Group Donors; EC 1.5.1.20/Methylenetetrahydrofolate Reductase (NADPH2)

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prognostic value of the acute DMSA scan in children with first urinary tract infection.
Next Document:  Ambulatory blood pressure monitoring after recovery from hemolytic uremic syndrome.